PEN

#702
Penumbra, Inc. Common Stock
318.3 0 USD
-0.41%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
318.23
318.82
年范围
3.19
362.41
日变化
-0.41%
每月变动
-2.26%
6个月变化
+7.67%
年变化
+22.42%
前一天收盘价
319.6 0
Open
318.3 5
最低价
318.2 3
High
318.8 2
交易量
525
展开完整图表 完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 12.52 B
  • Employee 4 700
  • Founded 2004
  • CEO Adam Elsesser
  • Website www.penumbrainc.com
  • Headquarter Delaware, United States
  • FIGI BBG001BP92V1
  • Industry 医疗器械
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
75.66
市销率
8.88

Penumbra, Inc. Common Stock

Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm. In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by yearend.

新闻